Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.4%

2 terminated/withdrawn out of 27 trials

Success Rate

91.3%

+4.8% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

43%

9 of 21 completed trials have results

Key Signals

4 recruiting9 with results

Enrollment Performance

Analytics

Phase 1
20(83.3%)
N/A
2(8.3%)
Phase 4
1(4.2%)
Phase 2
1(4.2%)
24Total
Phase 1(20)
N/A(2)
Phase 4(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials
NCT05098665Not ApplicableRecruiting

PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY

Role: collaborator

NCT04404062Recruiting

Serological and PCR Testing for COVID-19

Role: collaborator

NCT04873258Recruiting

Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease

Role: collaborator

NCT07014735Not ApplicableRecruiting

Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM

Role: lead

NCT03463044Phase 1Completed

Safety, Tolerability and Pharmacokinetic Profiles of MOTREM (LR12) in Healthy Male Subjects

Role: collaborator

NCT05160363Phase 1Completed

A Healthy Volunteer Safety Study of Pyronaridine Tetraphosphate Taken in Combination With Piperaquine Tetraphosphate

Role: collaborator

NCT04866602Phase 1Completed

Atoguanil BA Study

Role: collaborator

NCT01984827Phase 1Completed

Effect of Glucose on QTc Interval in Type 1 Diabetes

Role: collaborator

NCT00485667Phase 1Completed

Phase 1 Thorough QT Study in Young Healthy Volunteers

Role: collaborator

NCT04686669Phase 1Completed

A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet Formulations

Role: collaborator

NCT03709420Phase 1Completed

A Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics and Pharmacodynamics of FOR-6219

Role: collaborator

NCT04002687Phase 1Completed

Determine the Tolerability and Safety of Atovaquone-proguanil (ATV-PG) Co-administered With Amodiaquine (AQ)

Role: collaborator

NCT02495467Phase 2Completed

Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)

Role: collaborator

NCT04247230Phase 1Completed

Study to Determine the Effect of a Newly Formulated Tetracaine Product PET500 on Penile Skin Sensation

Role: collaborator

NCT02554799Phase 1Completed

A Study to Evaluate the Pharmacokinetics of Oral Formulations of MMV390048 Administered Fasted to Healthy Volunteers

Role: collaborator

NCT02885506Phase 1Completed

A FIH Study to Investigate the Safety, Tolerability and PK of P218

Role: collaborator

NCT01760187Phase 1Completed

Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C

Role: collaborator

NCT02945189Completed

Urine Sample Collection From Non Pregnant Peri and Post-menopausal Women

Role: collaborator

NCT02083666Phase 1Terminated

Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration

Role: collaborator

NCT02306629Phase 1Completed

Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood

Role: collaborator